Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed

OverviewStructured DataIssuesContributorsActivity
Is a
‌
Clinical study
0
Allocation Type
Randomized
0
Trial Collaborator
GlaxoSmithKline
GlaxoSmithKline
0
Intervention Model
Parallel Assignment
0
Intervention Name
Raxibacumab
0
Diphenhydramine
0
AVA
0
Interventional Trial Phase
Phase 4
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Biological
0
Drug
0
Last Updated
July 15, 2021
0
Masking Type
None (Open Label)
0
Primary Completion Date
January 3, 2017
0
Trial Recruitment Size
573
0
Trial Sponsor
Emergent BioSolutions
Emergent BioSolutions
0
Clinical Trial Start Date
February 24, 2015
0
Study Completion Date
June 6, 2017
0
Clinical Trial Study Type
Interventional
0
NCT Number
NCT02339155
0
Official Name
A Randomized, Open-label Study to Evaluate the Immunogenicity of Anthrax Vaccine Adsorbed Alone or Concomitantly With Raxibacumab (GSK3068483)
0
Official Website
clinicaltrials.gov/study...339155
0

Find more entities like Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.